Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Preannounces Q4 Revenues of $33.4M

NEW YORK (GenomeWeb) – Fluidigm said after the close of the market on Tuesday that its revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million.

On average, analysts were expecting Q4 revenues of $33.3 million for the South San Francisco, Calif.-based life science analytical and preparatory systems firm.

Organic revenue for Q4 — excluding revenue attributable to its acquisition of DVS Sciences in January 2014 — is expected to be approximately $25.2 million, which would be a 21 percent increase over the $20.9 million in revenues recorded by the company in Q4 2013.

Meantime, Fluidigm said that total revenue for full-year 2014 is expected to be $116.4 million, while organic revenue, less DVS Sciences' contribution, is expected to be $95.9 million.

Fluidigm projects total revenue of between $142 million and $149 million for full-year 2015. These projections incorporate an estimated negative currency-related impact of 3 percent to 4 percent at the midpoint of the range.

"We achieved strong sequential growth within our CyTOF single-cell proteomics product line both in terms of revenue and bookings," Fluidigm CEO Gajus Worthington said in a statement. "Our full-year results are at the high end of our previously stated guidance, despite a currency headwind in the quarter. As in the third quarter, we realized commercial synergy between single-cell genomics and proteomics at a customer and sales representative level."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.